Aptevo Therapeutics Inc.

APVO | NASDAQ | 0 Sledující

$4.72

0.43%

$0.02

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	0 -	0 -100.00%	3,114 -74.67%	12,292 -
Cost of revenue	0 -100.00%	567 -37.07%	901 -95.26%	18,994 -
Gross profit	0 +100.00%	-567 -125.62%	2,213 +133.02%	-6,702 -
Operating expense	24,602 -14.81%	28,878 -9.06%	31,755 -5.75%	33,692 -
Operating income	-24,602 +14.81%	-28,878 -0.83%	-28,641 -33.84%	-21,400 -
Pretax Income	-24,130 -29.38%	-18,650 -365.90%	7,014 +123.85%	-29,408 -
Tax Provision	0 -	0 +100.00%	-35,655 -1,601.91%	-2,095 -
Net income	-24,130 -38.59%	-17,411 -140.80%	42,669 +256.22%	-27,313 -
EPS	-84.67 -35.22%	-62.62 -190.42%	69.25 +125.93%	-267.09 -
Diluted EPS	-84.67 -35.22%	-62.62 -190.47%	69.21 +125.91%	-267.09 -
Average Shares	285 +2.50%	278 +139.88%	116 +8.80%	107 -
Diluted Average Shares	285 +2.50%	278 +139.76%	116 +8.85%	107 -
EBIT	0 +100.00%	-28,878 -0.83%	-28,641 -33.84%	-21,400 -
EBITDA	-24,602 +13.10%	-28,311 -2.06%	-27,740 -36.95%	-20,256 -

Soubory cookie používáme ke zlepšení prohlížení na webu.